Terminated NA INTERVENTIONAL 2-arm NCT00159146

Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

A Short Term Double Blind Randomised Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression

Sponsor: Hillerod Hospital, Denmark

Conditions Major Depression

Interventions Pindolol and venlafaxin

Updated 6 times since 2017 Last updated: Dec 20, 2007 Started: Aug 31, 2002 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of participants fulfilling inclusion criteria

Other terminated trials from Hillerod Hospital, Denmark

See all terminations from Hillerod Hospital, Denmark

Other Major Depression trials with similar outcome

Browse all Major Depression trials

Listed as NCT00159146, this NA trial focuses on Major Depression and remains terminated or withdrawn. Sponsored by Hillerod Hospital, Denmark, it has been updated 6 times since 2002, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hillerod Hospital, Denmark
Tvergaards Foundation
Wyeth is now a wholly owned subsidiary of Pfizer

Data source: Hillerod Hospital, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hillerød, Denmark